| NO. |
Chemical Name |
CAS NO. |
| Intermediates of Sacubitril |
| RCV001 |
(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-50-2 |
| Intermediates of Ezetimibe |
|
RCV002
|
(3R,4S)-1-(4-fluorophenyl)-3(R)-[[3-(4-fluorophenyl)-3(S)- -hydroxy-propyl]]-4(S)-(4-hydroxyphenyl)-2-azetidinone |
163222-33-1 |
|
RCV003
|
(3R,4S)-1-(4-fluorophenyl)-2-oxo-4-[4- (phenylmethoxy)phenyl]- 3-azetidinepropanoic acid, methyl ester, |
204589-80-0 |
|
RCV004
|
1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-[4-(phenylmethoxy)phenyl]-,(3R,4S)-2-Azetidinone |
163222-32-0 |
|
RCV005
|
N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline |
70627-52-0 |
|
RCV006
|
1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(phenylmethoxy)phenyl]-,(3R,4S)-2-Azetidinone |
190595-65-4 |
|
RCV007
|
3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl( amino)]] [4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)- 2-oxazolidinone |
272778-12-8 |
|
RCV008
|
3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-phenyl-(4S)-2-oxazolidinone |
189028-93-1 |
| Intermediates of Apixaban |
|
RCV057
|
3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro-1H-pyridin-2-one |
545445-44-1 |
|
RCV058
|
Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester |
27143-07-3 |
|
RCV009
|
ethyl 6-(4-iodophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
473927-64-9 |
|
RCV010
|
(S)-1-(tert-butoxycarbonyl)-4-oxopiperidine-2-carboxylic acid |
536759-91-8 |
|
RCV011
|
ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
503614-91-3 |
| Intermediates of Rivaroxaban |
|
RCV020
|
N-(2,3-Epoxypropyl)phthalimide |
5455-98-1 |
|
RCV016
|
(S)-N-(2,3-Epoxypropyl) phthalimide |
161596-47-0 |
|
RCV017
|
4-(4-aminophenyl)-3-morpholinone |
438056-69-0 |
|
RCV018
|
5-chlorothiophene-2-carbonyl chloride |
42518-98-9 |
| Intermediates of Regadenoson |
|
RCV053
|
Ethyl 2-Formyl-3-Oxopropanoate |
80370-42-9 |
| Intermediates of Argatroban |
|
RCV023
|
3-Methyl-quinoline-8-sulfonyl chloride |
74863-82-4 |
|
RCV024
|
Ethyl (2R,4R)-1-[(2S)-2-amino-5-[[imino(nitroamino)methyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylate hydrochloride salt |
74874-08-1 |
| Intermediates of Bosentan |
|
RCV025
|
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine |
150728-13-5 |
|
RCV026
|
4-tert-Butylbenzenesulphonamide |
6292-59-7 |
|
RCV027
|
5-(2-methoxyphenoxy)-2,2'-bipyrimidine-4,6-dione |
150728-12-4 |
| Intermediates of Candesartan |
|
RCV028
|
1-chloroethyl-cyclohexyl carbonate |
99464-83-2 |
|
RCV029
|
Trityl Candesartan; 2-ethoxy-1-[2'-(1-triphenylmethyltetrazol-5-yl)-biphenyl-4-ylmethyl]-benzimidazole-7-carboxylate |
139481-72-4 |
|
RCV030
|
Trityl Candesartan Cilexitil;
(1-cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2'-(1-triphenylmethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4yl]methyl]-1H-benzimidazole-7-carboxylate) |
170791-09-0 |
| Intermediates of Irbesartan |
|
RCV033
|
4’-(2-butyl-4-oxo-1,3-diazaspiro[4,4]non-1-en-3-ylmethyl)biphenyl-2-carbonitrile |
138401-24-8 |
| Intermediates of Telmisartan |
|
RCV036
|
Telmisartan Methyl Ester |
528560-93-2 |
|
RCV037
|
2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole |
152628-02-9 |
|
RCV039
|
4'-bromomethylbiphenyl-2-carboxylic acid methyl ester |
114772-38-2 |
| Intermediates of Atorvastatine |
|
RCV053
|
ATS-9; (4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate |
125995-13-3 |
|
RCV054
|
M-4; 2-[2-(4-Fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxo-N-phenylpentanamide |
125971-96-2 |
|
RCV055
|
L-1; tert-Butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate |
125971-95-1 |
